GlassScriptPhysician profile
Kristen E Bailey Mills
NPI 1619473816
$717.57
in general payments reported to CMS, 2019-2025
14 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $72.89 · 2023: $281 · 2024: $88.15 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.77 | 2021-2025 | |
| Qol Medical, LLC | $151.21 | 2023 | Sucraid |
| Abbott Laboratories | $54.27 | 2024 | Freestyle Libre 3 |
| Corcept Therapeutics | $36.16 | 2025 | Korlym |
| Exact Sciences Corporation | $28.87 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Alfasigma USA, INC. | $27.59 | 2022 | |
| Grifols USA, LLC | $23.52 | 2023 | Gamunex-C |
| Antares Pharma, INC. | $22.75 | 2021 | |
| Ibsa Pharma INC. | $20.72 | 2025 | Flector, Licart, Tirosint |
| Halozyme INC | $16.59 | 2023 | |
| Pfizer INC. | $15.00 | 2024 | |
| Glaxosmithkline, LLC. | $14.73 | 2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $14.06 | 2023 | Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Bailey Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.